Not applicableStudy completedNCT02679170
What this trial is testing
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)
Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 692